Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 9c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Raymond James cuts Delta and JetBlue ratings ahead of Q2 earnings
• Morgan Stanley Downgrades Seven & i Holdings Co Ltd (3382:JP) (SVNDF) to Equalweight, Earnings US May Peak F2/27